+ All Categories
Home > Documents > Future challenges for HIV prevention & treatment in high-risk populations

Future challenges for HIV prevention & treatment in high-risk populations

Date post: 14-Jan-2016
Category:
Upload: hayes
View: 28 times
Download: 0 times
Share this document with a friend
Description:
Future challenges for HIV prevention & treatment in high-risk populations. Professor Anna Mia Ekström HIV/AIDS & Global Health Research Group. People living with HIV: 35.3 (32.2-38.8) million. 40 000 000. 35 000 000. 30 000 000. 25 000 000. 20 000 000. 15 000 000. 10 000 000. - PowerPoint PPT Presentation
Popular Tags:
18
Future challenges for HIV prevention & treatment in high-risk populations Professor Anna Mia Ekström HIV/AIDS & Global Health Research Group
Transcript
Page 1: Future challenges for HIV prevention & treatment  in high-risk populations

Future challenges forHIV prevention & treatment in high-risk populations

Professor Anna Mia Ekström

HIV/AIDS & Global Health Research Group

Page 2: Future challenges for HIV prevention & treatment  in high-risk populations

People living with HIV: 35.3 (32.2-38.8) million40 000 000

30 000 000

20 000 000

10 000 000

0

People living with HIV in the world

35 000 000

25 000 000

15 000 000

19901991 1992 1993 199419951996 1997 1998 199920002001 2002 2003 200420052006 2007 2008 20092010

5 000 000

Anna Mia Ekström Source: UNAIDS 2011

Page 3: Future challenges for HIV prevention & treatment  in high-risk populations

Anna Mia Ekström, HIV& AIDS Research Group

Page 4: Future challenges for HIV prevention & treatment  in high-risk populations

New HIV infections and AIDS-related deaths

4 000 000

3 000 000

2 000 000

1 000 000

0

Peo

ple

New HIV infections

3 500 000

2 500 000

1 500 000

500 000

19901991 1992 1993 199419951996 1997 1998 199920002001 2002 2003 200420052006 2007 2008 20092010

AIDS-related deaths

2.3 (1.9-2.7) million

1.6 (1.4-1.9) million

Anna Mia Ekström Source: UNAIDS 2011

Page 5: Future challenges for HIV prevention & treatment  in high-risk populations

Anna Mia Ekström, HIV& AIDS Research Group

Page 6: Future challenges for HIV prevention & treatment  in high-risk populations

• Male circumcision

• Prevent mother to child transmission (PMTCT)

• Antiretroviral treatment

• Safer sex (partners, condoms)

• HIV-testing

Methods for hiv-prevention

Anna Mia Ekström, HIV& AIDS Research Group

Page 7: Future challenges for HIV prevention & treatment  in high-risk populations

Real-life effectiveness?

Male circumcision reduced by 60% (?)

Anna Mia Ekström, HIV& AIDS Research Group

Page 8: Future challenges for HIV prevention & treatment  in high-risk populations

Prevention of mother to child transmission (PMTCT) risk down from 33% to<5%.

Anna Mia Ekström, HIV& AIDS Research Group

Page 9: Future challenges for HIV prevention & treatment  in high-risk populations

Source Of Funds

Procurement Agent/Body

Point of 1st warehousing

Point of 2nd warehousing

MEDICAL STORE

PRIMARY HEALTH CARE FACILITYDISTRICT STORE

ZONAL MEDICAL STORE

ESSENTIAL MEDICINES

ARVs MALARIA TB OIARVs Ped

REAGENT Blood safety(+ HIV test)

VACCINES CONDOMS CONTRACEPTIVESMEDICALSUPPLIES

REGIONAL/DISTRICT VACCINE STORE

HEALTH FACILITY

GOVERNMENT

MULTILATERAL DONOR

BILATERAL DONOR

NGO/PRIVATE

AXIOSTEC &CC

T

CRS IMA CUAMMHOSPITAL COLUMBIA HOSPITAL

TEC &CC

T

HEALTH FACILITY

HEALTH FACILITY HOSPITALTEC &CC

T

ZONAL BLOOD SAFETY CENTRE

Point of Distribution

GOVERNMENT

WBGLOBAL

FUND

SIDA

PEPFAR

USAID

UNICEF

WHO

ABBOTT

CSSC

COLUMBIA

PFIZER

JICA

CLINTON

UNITAID

CIDA

CDC

GAVI

CUAMM

HAVARD

NORAD

HOSPITAL

TEC&

CCT

CLINTON

HAVARD

MEDICALSTORE

CRS

SCMS

EGPAF

MOH& SW

AXIOS

UNICEF

JICA

CDC

COLUMBIA

ABBOTT

GAVI

CUAMM

CROWNAGENTS

USAID

TMAP

AXIOS

PATIENT

Weak health systems prevent effective implementation (ARVMAC, KI coordinated EU project)

Source: MOHSW & WHO. Courtesy of Don de Savigny

Anna Mia Ekström, HIV& AIDS Research Group

Page 10: Future challenges for HIV prevention & treatment  in high-risk populations

PMTCT in reality: only 1/10 complete the full program

Anna Mia Ekström, HIV& AIDS Research Group

Page 11: Future challenges for HIV prevention & treatment  in high-risk populations

Antiretroviral treatment: miracle drugs!

Saves lives! Reduce viral load, strenghten the immune defense, reduces risk of transmission by 96%

….but expensive, demans monitoring structures/staff, livlife long adherence due to high drug resistsnce risk and potentially serious side effects

Anna Mia Ekström, HIV& AIDS Research Group

Page 12: Future challenges for HIV prevention & treatment  in high-risk populations

Anna Mia Ekström, HIV& AIDS Research Group

Page 13: Future challenges for HIV prevention & treatment  in high-risk populations

Anna Mia Ekström, HIV& AIDS Research Group

Access to ART up by 60% last 24 months in low and middle income countries

Now: 8 million on ART (dec 2012)

Page 14: Future challenges for HIV prevention & treatment  in high-risk populations

Safer sex? HIV transmission in sexual networks

Man”Bank book””Girl friends”

”Weekend get-away”Anna Mia Ekström, HIV& AIDS Research Group

Page 15: Future challenges for HIV prevention & treatment  in high-risk populations

Vision Research Group

To contribute to evidence-based HIV prevention, treatment and care in resource-poor contexts with high HIV prevalence and among marginalized groups at high risk

Anna Mia Ekström, HIV& AIDS Research Group

Page 16: Future challenges for HIV prevention & treatment  in high-risk populations

Research in populations with high HIV prevalance and in marginalized groups at high risk

Anna Mia Ekström, HIV& AIDS Research Group

Page 17: Future challenges for HIV prevention & treatment  in high-risk populations

Who?

40 senior & affiliated researchers, postdocs, PhD students

Strong international network: universities, public & private partners

How?

Innovative, Interdisciplinary, Implementable!

Virology- clinic-epidemiology-policy

Population-baserade epidemiologiska studies HDSS, RDS, health

systems, qualitative methods, clinical cohorts collaboration with

Karolinska University Hospital and multiple clinics and hospitals abroad

Capacity building & international PhD exchange

ERA evaluation?

Excellent

Research group activities in brief

Page 18: Future challenges for HIV prevention & treatment  in high-risk populations

For more information, please see:Research group “HIV/AIDS and Global Health”

http://ki.se/research/[email protected]

AND TODAY:

Asli Kulane/Mohamad Farah: Visuals in health education for Somali immigrants

Keshab Debua: HIV in Nepal: surveillance among marginalized youth

Hanani Tabana: couple testing in South Africa

Rolling ppt on ARVMAC: results from EU project on ART scale-up (plan 8)

Anna Thorson/Susanne Strömdahl: Poster on HIV among MSM (ECDC)


Recommended